Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Inhibitex News Editors

News Widget

Display the Inhibitex news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Inhibitex News

News on Inhibitex (Ticker: INHX) continually updated from thousands of sources around the net.

Feb 13, 2012 | Medical News

Bristol-Myers completes tender offer for Inhibitex

Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb, Health

Fri Feb 10, 2012

Information Technology

BUYINS.NET: TRLG, ANR, CMRG, MCHX, INHX, EFSC Are Seasonally Ripe To Go Up In the Next Five Weeks

Feb 10, 2012 -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of TRUE RELIGION APPAREL INC.

Comment?

Related Topix: Annuity and Life Re Holdings, Insurance, Marchex, Biotech, Medicine, Healthcare Industry, Marketing, Vernon, CA

Fri Feb 03, 2012

Wall St. Cheat Sheet

Gilead Up 6% After Positive Hep-C Trial

Though guidance for the year had been weaker than expected after a down fourth quarter, Gilead's research chief announce results of their anti-hepatitis C treatment.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Pharmaceuticals, Pharmasset, Bristol Myers Squibb, Startups

Mon Jan 30, 2012

Wall St. Cheat Sheet

J.C. Penney, Jazz Pharma and Healthspring Lead These 52-Week High Stocks Today

Advance Auto Parts : UBS upgraded Advance Auto Parts based on expectations for improved operating performance due to its streamlined focus.

Comment?

Related Topix: JC Penney, Retail, Advance Auto Parts, Financial Markets, Auto Parts, Cigna, Insurance, Biotech, Medicine, Healthcare Industry, Startups, Jazz Pharmaceuticals

AmericanBankingNews.com

Inhibitex (INHX) Shares Downgraded to "Market Perform" by William Blair Analysts

Inhibitex was downgraded by equities research analysts at William Blair from an "outperform" rating to a "market perform" rating in a research note issued to investors on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Chickenpox, Health

Los Angeles Jobs

Also on Topix